Showing results (231-240 of 316) with videos related to

Sort By:
Pageof 32
Cell Death Discovery|July 13, 2022
Neddylation tunes peripheral blood mononuclear cells immune response in COVID-19 patientsMarina Serrano-Maciá, Sofia Lachiondo-Ortega, Paula Iruzubieta, et al.
Journal of Clinical Medicine|November 11, 2020
Is Routine Prophylaxis Against Pneumocystis jirovecii Needed in Liver Transplantation? A Retrospective Single-Centre Experience and Current Prophylaxis Strategies in SpainJosé Ignacio Fortea, Antonio Cuadrado, Ángela Puente, et al.
Journal of Clinical Medicine|June 19, 2019
MicroRNA Profile of HCV Spontaneous Clarified Individuals, Denotes Previous HCV InfectionÓscar Brochado-Kith, Alicia Gómez Sanz, Luis Miguel Real, et al.
Journal of Hepatology|January 7, 2015
STARTVerso1: A randomized trial of faldaprevir plus pegylated interferon/ribavirin for chronic HCV genotype-1 infectionPeter Ferenci, Tarik Asselah, Graham R Foster, et al.
Molecular Metabolism|July 17, 2024
Cathepsin D is essential for the degradomic shift of macrophages required to resolve liver fibrosisPaloma Ruiz-Blázquez, María Fernández-Fernández, Valeria Pistorio, et al.
Journal of Clinical Gastroenterology|June 23, 2016
Altered Underlying Renal Tubular Function in Patients With Chronic Hepatitis B Receiving Nucleos(t)ide Analogs in a Real-World Setting: The MENTE StudySonia Rodríguez-Nóvoa, Javier García-Samaniego, Martín Prieto, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 14, 2019
Development and Validation of Hepamet Fibrosis Scoring System-A Simple, Noninvasive Test to Identify Patients With Nonalcoholic Fatty Liver Disease With Advanced FibrosisJavier Ampuero, Raluca Pais, Rocío Aller, et al.
Annals of Hepatology|May 29, 2015
High efficacy and safety of triple therapy in HCV genotype 1 and moderate fibrosis: a multicenter study of clinical practice in SpainJavier Crespo, Moisés Diago, Joaquín Cabezas, et al.
Scientific Reports|August 13, 2016
Imaging biomarkers for steatohepatitis and fibrosis detection in non-alcoholic fatty liver diseaseRocío Gallego-Durán, Pablo Cerro-Salido, Emilio Gomez-Gonzalez, et al.
Digestive Diseases and Sciences|January 13, 2017
Effectiveness and Safety of Entecavir or Tenofovir in a Spanish Cohort of Chronic Hepatitis B Patients: Validation of the Page-B Score to Predict Hepatocellular CarcinomaMar Riveiro-Barciela, David Tabernero, José L Calleja, et al.
Pageof 32